Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Medexus Pharmaceuticals Inc
(OP:
MEDXF
)
1.700
UNCHANGED
Streaming Delayed Price
Updated: 3:50 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.700
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
1.700
Today's Range
1.700 - 1.700
52wk Range
1.060 - 2.350
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 18, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
April 11, 2023
Annual revenue expected to exceed US$107 million for fiscal year ended March 31, 2023, an all-time record, including fiscal Q4 2023 revenue of at least US$28 million
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Performance
YTD
-11.46%
-11.46%
1 Month
-8.11%
-8.11%
3 Month
-6.28%
-6.28%
6 Month
+41.67%
+41.67%
1 Year
+55.96%
+55.96%
More News
Read More
Medexus Announces New License Deal for Topical Terbinafine
March 22, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Announces US$58.5 million in New Credit Facilities
March 08, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Pharmaceuticals Inc. (TSX: MDP) (OTCQX: MEDXF) Featured in Coverage of the 35th Annual Roth Conference
March 06, 2023
Via
Investor Brand Network
Medexus to Participate in 35th Annual Roth Conference
March 06, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
February 08, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Welcomes Two New Board Members
February 06, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
February 01, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
January 31, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
January 12, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
November 08, 2022
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Schedules Second Quarter 2023 Conference Call
November 02, 2022
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023
October 06, 2022
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Medexus and MidCap Agree to Increase in MidCap’s Revolving Loan Commitment Amount
September 29, 2022
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
January 28, 2022
From
MicroCap Rodeo
Via
AccessWire
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
December 06, 2021
From
Stock News Now
Via
AccessWire
Making a Difference When You Invest? Medexus Says It Improves Lives
November 10, 2021
Via
Benzinga
Sidoti Microcap Virtual Conference
November 05, 2021
From
Sidoti & Company, LLC
Via
AccessWire
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2021
August 18, 2021
Via
Benzinga
Medexus Pharmaceuticals to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021
August 10, 2021
From
Medexus Pharmaceuticals Inc.
Via
AccessWire
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
August 16, 2021
From
Stock News Now
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Sidoti Microcap Virtual Conference
May 18, 2021
From
Sidoti & Company, LLC
Via
AccessWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
